09:28 AM EDT, 07/22/2024 (MT Newswires) -- BWX Technologies ( BWXT ) subsidiary BWXT Medical and NorthStar Medical Radioisotopes said Monday they signed a master services agreement to produce actinium-225, a medical isotope for cancer treatment.

Under the multi-year agreement, the companies will collaborate to process and purify radium-226 to generate actinium-225, with potential projects for target design and backup supply support for each other's customers.

Financial details were not disclosed.

Price: 102.51, Change: +0.51, Percent Change: +0.50